Budget Impact of Harmonic FOCUS in Thyroidectomy (TIME)

August 1, 2012 updated by: Pablo Moreno Llorente, Hospital Universitari de Bellvitge

Harmonic FOCUS Versus Conventional Technique in Total Thyroidectomy for Benign Thyroid Disease. A Randomized, Prospective Study

Study Design Multinodular Goiter (MNG) patients requiring surgery were referred to the Endocrine Surgery Unit.

Indirect laryngoscopy was routinely performed preoperatively to assess normal motility in vocal folds (VF). Ultrasounds (US) study was performed the month previous to surgery to evaluate thyroid volume. Eligible patients met the following criteria: to have MNG, age between 18 and 80 and consent to be included in the study. Exclusion criteria included previous neck surgery, vocal fold impairment, permanent or transitory NSAID or analgesic treatment, coagulation disorders and any cognitive impairment.

Eligible patients were proposed to enter a randomized study with 2 arms in which we compared the use of two harmonic scalpel devices: ACE14S and Harmonic Focus (Ethicon Endo-Surgery, Cincinnati, OH, USA).

The main endpoint was operative time. Secondary endpoints were total and relative (%) time of use of the device along thyroidectomy, recurrent laryngeal nerve (RLN) injury and hypocalcaemia (both persistent or temporary), number of ligatures, length of skin incision, postoperative pain according to a visual scale of pain, QOL after thyroidectomy (EuroQOL) and budget impact analysis.

All patients were operated on by 2 surgeons, one senior (responsible for the Endocrine Surgery Unit) and one junior under supervision.

Randomization Randomization was performed the same day of surgery at the OR by using a closed envelope. Patients were randomized to Group I (ACE14S) or Group II (HF) and allocated in a 1:1 proportion; they reminded blinded until the end of the study about the device used.

The haemostasis device was communicated to the surgeon previous to start surgery. Medical staff of the Endocrine Surgery Unit collected clinical data.

Surgical Technique Total thyroidectomy (TT), defined as total bilateral extracapsular lobectomy 9, was performed using HF or ACE14S for vessel division. Monopolar and bipolar forceps for cutting and coagulation were routinely used. Ties were used under surgeon's criteria according to size of the vessels and/or the need to obtain haemostasis in the vicinity of the RLN when bipolar forceps were not considered safe enough.

Study Overview

Status

Unknown

Conditions

Detailed Description

OBJECTIVE:

To disclose the potential advantages and outcomes of the new Harmonic Focus (HF) device compared to Harmonic Scalpel ACE14S (ACE-14S) in benign thyroid surgery.

STUDY DESIGN:

Controlled randomized study.

METHODS:

Harmonic Focus was compared to former ACE14S device in patients undergoing total thyroidectomy for Multinodular Goiter. The primary endpoint was time of surgery. Secondary endpoints were time of use of the device, % of use along the procedure, number of ligatures, blood loss, hypocalcaemia, recurrent laryngeal nerve impairment, postoperative pain and quality of life.

Study Type

Observational

Enrollment (Actual)

56

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • L'Hospitalet, Barcelona, Spain, 08907
        • Hospital UIniversitari de Bellvitge

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Eligible patients met the following criteria: to have MNG, age between 18 and 80 and consent to be included in the study.

Eligible patients were proposed to enter a randomized study with 2 arms in which we compared the use of two harmonic scalpel devices: ACE14S and Harmonic Focus (Ethicon Endo-Surgery, Cincinnati, OH, USA).

Description

Inclusion Criteria:

  • Multinodular goiter (MNG), age between 18 and 80 and consent to be included in the study

Exclusion Criteria:

  • previous neck surgery
  • vocal fold impairment
  • permanent or transitory NSAID or analgesic treatment,
  • coagulation disorders
  • any cognitive impairment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study group: HARMONIC FOCUS®
Total thyroidectomy (total bilateral extracapsular lobectomy) for Multinodular Goiter with HARMONIC FOCUS®
Total thyroidectomy (total bilateral extracapsular lobectomy) for Multinodular Goiter with HARMONIC FOCUS®
Other Names:
  • FOCUS Curved Shear, Code:FCS9 (EES, Cincinnati, OH, USA)
Control group: ACE14S
Total thyroidectomy (total bilateral extracapsular lobectomy) for Multinodular Goiter with ACE14S
Total thyroidectomy (total bilateral extracapsular lobectomy) for Multinodular Goiter with ACE14S
Other Names:
  • ACE® Curved Shears, Code: ACE14S (EES, Cincinnati, OH, USA)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operative time
Time Frame: Surgical time from skin incision to closure (about 70 minutes)
Operative time was measured from skin incision to removal of thyroid gland. The percentage of time using the device along TT was calculated as follows: time of use of the device x 100/ operative time.
Surgical time from skin incision to closure (about 70 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total and relative (%) time of use of the device along thyroidectomy
Time Frame: From skin incision to removal of thyroid gland (about 30 minutes)
The percentage of time using the device along surgery was calculated as follows: time of use of the device x 100/ operative time.
From skin incision to removal of thyroid gland (about 30 minutes)
Recurrent laryngeal nerve (RLN) injury
Time Frame: From surgery to 6 months
Patients with laryngeal nerve injury were controlled monthly by indirect laryngoscopy till 6 months or healing.
From surgery to 6 months
hypocalcemia (both persistent or temporary)
Time Frame: Daily, from surgery to discharge (24h), or up to 6 months

Temporary hypocalcemia was measured daily, from surgery to discharge.

Persistent hypocalcemia was followed up as follows:

  • Non-complicated patients: one week and six months after the operation date.
  • Complicated patients: every month until cure or up to 6 months after surgery.
Daily, from surgery to discharge (24h), or up to 6 months
postoperative pain according to a visual scale of pain
Time Frame: From surgery to 7 days
Pain evaluation was obtained at 24h and 7 days after surgery during postoperative control by using an analogue-visual scale reporting also the type of analgesic and the number of doses. If there was any complication (including reoperation) that increased hospital stay, pain evaluation was performed each 24h until discharge.
From surgery to 7 days
QOL after thyroidectomy (EuroQOL)
Time Frame: 1st and 7th postoperative day
QOL was evaluated by completing EQ-5D questionnaire when patients were scheduled for the study (1st and 7th postoperative day)
1st and 7th postoperative day
Number of ligatures
Time Frame: Day of surgery
Number of ligatures during the procedure was measured to determine if its reduction would imply less surgical time consumption
Day of surgery
Length of skin incision
Time Frame: Day of surgery
Measured at the end of the operation, once the skin was closured.
Day of surgery
budget impact analysis
Time Frame: From surgery to discharge (24h)
costs of total thyroidectomy (all of them according to the prices of our center) and deducting those time-dependent costs saved with the reduction of OR time. The following concepts were considered: personnel (with the same surgical team composition for both alternatives), anesthesia drugs, medical devices, overheads, repayment of the Harmonic generator, hospital stay and admission/discharge fees.
From surgery to discharge (24h)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pablo Moreno, MD, PhD, Hospital UIniversitari de Bellvitge

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2009

Primary Completion (Actual)

March 1, 2010

Study Completion (Anticipated)

August 1, 2012

Study Registration Dates

First Submitted

July 17, 2012

First Submitted That Met QC Criteria

August 1, 2012

First Posted (Estimate)

August 6, 2012

Study Record Updates

Last Update Posted (Estimate)

August 6, 2012

Last Update Submitted That Met QC Criteria

August 1, 2012

Last Verified

August 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multinodular Goiter

Clinical Trials on HARMONIC FOCUS®

Subscribe